These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3362274)

  • 1. Reduced incidence of hyperkalemia and azotemia in patients receiving sulindac compared with indomethacin.
    Nesher G; Zimran A; Hershko C
    Nephron; 1988; 48(4):291-5. PubMed ID: 3362274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperkalemia associated with sulindac therapy.
    Nesher G; Zimran A; Hershko C
    J Rheumatol; 1986 Dec; 13(6):1084-5. PubMed ID: 3560096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent hyperkalemia and acute renal failure following sulindac therapy.
    Horowitz J; Sukenik S; Altz-Smith M
    Isr J Med Sci; 1988 Aug; 24(8):433-4. PubMed ID: 3410675
    [No Abstract]   [Full Text] [Related]  

  • 4. Indomethacin-associated hyperkalemia in the elderly.
    Meier DE; Myers WM; Swenson R; Bennet WM
    J Am Geriatr Soc; 1983 Jun; 31(6):371-3. PubMed ID: 6853948
    [No Abstract]   [Full Text] [Related]  

  • 5. Sulindac. A potentially renal-sparing nonsteroidal anti-inflammatory drug.
    Bunning RD; Barth WF
    JAMA; 1982 Dec; 248(21):2864-7. PubMed ID: 7143649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of indomethacin and sulindac with labetalol.
    Abate MA; Neely JL; Layne RD; D'Alessandri R
    Br J Clin Pharmacol; 1991 Mar; 31(3):363-6. PubMed ID: 2054279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulindac in ankylosing spondylitis. Double-blind evaluation of sulindac and indomethacin.
    Calin A; Britton M
    JAMA; 1979 Oct; 242(17):1885-6. PubMed ID: 480622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimethoprim-sulfamethoxazole therapy in outpatients: is hyperkalemia a significant problem?
    Alappan R; Buller GK; Perazella MA
    Am J Nephrol; 1999; 19(3):389-94. PubMed ID: 10393376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind study comparing sulindac with indomethacin in rheumatoid arthritis.
    Lund HI; Donde R; Petersen PH
    Scand J Rheumatol Suppl; 1980; 37():1-6. PubMed ID: 7013055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of indomethacin and sulindac on blood pressure of hypertensive patients.
    Lewis RV; Toner JM; Jackson PR; Ramsay LE
    Br Med J (Clin Res Ed); 1986 Apr; 292(6525):934-5. PubMed ID: 3083945
    [No Abstract]   [Full Text] [Related]  

  • 11. Coadministration of estradiol/drospirenone and indomethacin does not cause hyperkalemia in healthy postmenopausal women: a randomized open-label crossover study.
    Schütt B; Kunz M; Blode H
    J Clin Pharmacol; 2007 Jun; 47(6):774-81. PubMed ID: 17463217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of selective and nonselective prostaglandin inhibition on renin.
    Pedrinelli R; Magagna A; Abdel-Haq B; Salvetti A
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():147-50. PubMed ID: 3159197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indomethacin-induced azotaemia and hyperkalaemia: a case study.
    Nicholls MG; Espiner EA
    N Z Med J; 1981 Nov; 94(696):377-9. PubMed ID: 7033849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of interaction between sulindac or naproxen and propranolol in hypertensive patients.
    Schuna AA; Vejraska BD; Hiatt JG; Kochar M; Day R; Goodfriend TL
    J Clin Pharmacol; 1989 Jun; 29(6):524-8. PubMed ID: 2666452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of indomethacin and sulindac on some pharmacological actions of atenolol in hypertensive patients.
    Salvetti A; Pedrinelli R; Alberici P; Magagna A; Abdel-Haq B
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):108S-111S. PubMed ID: 6378233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperkalemia associated with indomethacin.
    Goldszer RC; Coodley EL; Rosner MJ; Simons WM; Schwartz AB
    Arch Intern Med; 1981 May; 141(6):802-4. PubMed ID: 7016059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological study of the effects of three anti-inflammatory preparations on the gastric mucosa.
    McIntyre RL; Irani MS; Piris J
    J Clin Pathol; 1981 Aug; 34(8):836-42. PubMed ID: 7276205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of indomethacin and sulindac on hydrochlorothiazide kinetics.
    Koopmans PP; Kateman WG; Tan Y; van Ginneken CA; Gribnau FW
    Clin Pharmacol Ther; 1985 Jun; 37(6):625-8. PubMed ID: 3891188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal failure and nephrotic syndrome associated with sulindac.
    Champion de Crespigny PJ; Becker GJ; Ihle BU; Walter NM; Wright CA; Kincaid-Smith P
    Clin Nephrol; 1988 Jul; 30(1):52-5. PubMed ID: 3208459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal prostaglandin E2 and F2 alpha synthesis during exercise: effects of indomethacin and sulindac.
    Zambraski EJ; Dodelson R; Guidotti SM; Harnett CA
    Med Sci Sports Exerc; 1986 Dec; 18(6):678-84. PubMed ID: 3537627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.